Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999;Neuroblastomes localisés du nouveau-né: 52 cas traités de 1990 à 1999

Archives de Pediatrie

Volumn 11, Issue 7, 2004, Pages 782-788

  Michalowski, M B ^a   Rubie, H ^b   Michon, J ^c   Montamat, S ^c   Bergeron, C ^d   Coze, C ^e   Perel, Y ^f   Valteau Couanet, D ^g   Guitard, J ^b   Guys, J M ^e   Piolat, C ^a   Munzer, C ^b   Plantaz, D ^a  

^a HÔPITAL MICHALLON   (France)

^b HÔPITAL DES ENFANTS   (France)

^c INSTITUT CURIE   (France)

^d CENTRE LÉON BÉRARD   (France)

^e TIMONE HOSPITAL   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Infant, newborn; Neuroblastoma; Neuroblastome; Nouveau n

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL TUMOR; ADRENAL TUMOR; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CHILDHOOD CANCER; CHILDHOOD MORTALITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NEPHRECTOMY; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEWBORN; ONCOGENE C MYB; PELVIS TUMOR; POSTOPERATIVE COMPLICATION; PRENATAL DIAGNOSIS; PROGNOSIS; THORAX TUMOR; TUMOR VOLUME; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3242762126     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.01.020     Document Type: Article

References (35)

1. Campbell A.N., Chan H.S., O'Brien A., Smith C.R., Becker L.E. Malignant tumours in the neonate. Arch Dis Child. 62:1987;19-23
2. Cecchetto G., Previtera C., Messineo A., Longo M., Guglielmi M. Neonatal malignant solid tumors. Tumori. 76:1990;81-83
3. Teinturier C., Kalifa C., Hartmann O., Flamant F., Lemerle J. Tumeurs solides malignes néonatales. À propos de 75 cas. Arch Fr Pediatr. 49:1992;187-192
4. Bader J.L., Miller R.W. US cancer incidence and mortality in the first year of life. Am J Dis Child. 133:1979;157-159
5. Borch K., Jacobsen T., Olsen J.H., Hirsch F., Hertz H. Neonatal cancer in Denmark 1943-1985. Pediatric Hematol Oncol. 9:1992;209-216
6. Sauvat F., Sarnacki S., Brisse H., Medioni J., Rubie H., Aigrain Y., et al. Outcome of suprarenal localized masses diagnosed during the perinatal period. A retrospective multicenter study. Cancer. 94:2002;2474-2480
7. Crom D.B., Wilimas J.A., Green A.A., Pratt C.B., Jenkins J.J. 3rd, Behm F.G. Malignancy in the neonate. Med Pediatr Oncol. 17:1989;101-104
8. Gale G.B., D'Angio G.J., Uri A., Chatten J., Koop C.E. Cancer in neonates: the experience at the Children's Hospital of Philadelphia. Pediatrics. 70:1982;409-413
9. Isaacs H. Jr. Congenital and neonatal malignants tumors. A 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol. 9:1987;121-129
10. De Bernardi B., Conte M., Mancini A., Donfrancesco A., Alvisi P., Toma P., et al. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 13:1995;884-893
11. Le Tourneau J.N., Bernard J.L., Hendren W.H., Carcassonne M. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg. 20:1985;244-249
12. Haase G.M., Wong K.Y., de Lorimier A.A., Sather H.N., Hammond G.D. Improvement in survival after excision of primary tumor in Stage III neuroblastoma. J Pediatr Surg. 24:1989;194-200
13. Tsuchida Y., Ikeda H., Iehara T., Toyoda Y., Kawa K., Fukuzawa M. Neonatal neuroblastoma: incidence and clinical outcome. Med Pediatr Oncol. 40:2003;391-393
14. Garaventa A., De Bernardi B., Pianca C., Donfrancesco A., Cordero di Montezemolo L., Di Tullio M.T., et al. Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. J Clin Oncol. 11:1993;1770-1779. Italian Cooperative Group of Neuroblastoma
15. Rubie H., Plantaz D., Coze C., Michon J., Frappaz D., Baranzelli M.C., et al. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Med Pediatr Oncol. 36:2001;247-250. Neuroblastoma Study Group, Société Française d'Oncologie
16. West D.C., Shamberger R.C., Macklis R.M., Kozakewich H.P., Wayne A.S., Kreissman S.G., et al. Stage III neuroblastoma over 1 year at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol. 11:1993;84-90
17. Rosen E.M., Cassady J.R., Kretschmar C., Frantz N., Levey R., Sallan S.E. Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol. 12:1984;260-263
18. Rubie H., Hartmann O., Michon J., Frappaz D., Coze C., Chastagner P., et al. N-myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. J Clin Oncol. 15:1997;1171-1182. Neuroblastoma Study Group of the Société Françaie d'Oncologie Pédiatrique
19. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol. 11:1993;1466-1477
20. Parkes S.E., Muir K.R., Southern L., Cameron A.H., Darbyshire P.J., Stevens M.C. Neonatal tumours: a thirty-year population based study. Med Pediatr Oncol. 22:1994;309-317
21. Granata C., Fagnani A.M., Gambini C., Boglino C., Bagnulo S., Cecchetto G., et al. Features and Outcome of neuroblastoma detected before birth. J Pediatr Surg. 35:2000;88-91
22. Sbragia L., Paek B.W., Feldstein V.A., Farrel J.A., Harrison M.R., Albanese C.T., et al. Outcome of prenataly diagnosed solid fetal tumors. J Pediatr Surg. 36:2001;1244-1247
23. Moppett J., Haddadin I., Foot A.B. Neonatal neuroblastoma. Arch Dis Child Fetal Neonatal Ed. 81:1999;F134-F137
24. Kawakami T., Monobe Y., Monforte H., Woods W.G., Tuchman M., Lemieux B., et al. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project. Cancer. 83:1998;575-581
25. Beckwith J.B., Martin R.F. Observations on the histopathology theory of neuroblastomas. J Pediatr Surg. 3:1968;106-110
26. Turkel S.B., Hitabashi H.H. The natural history of neuroblastic cells in fetal adrenal gland. Am J Pathol. 76:1974;225-244
27. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J Clin Oncol. 17:1999;2264-2279
28. Yamamoto K., Hanada R., Kikuchi A., Ichikawa M., Aihara T., Oguma E., et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 16:1998;1265-1269
29. Woods W.G., Tuchman M., Robinson L.L., Bernstein M., Leclerc J.M., Brisson L.C., et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet. 348:1996;1682-1687
30. Bessho F. Effects of mass screening on age-specific incidence of neuroblastoma. Int J Cancer. 67:1996;520-522
31. Plantaz D., Hartmann O., Kalifa C., Sainte-Rose C., Lemoine G., Lemerle J. Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol. Med Pediatr Oncol. 21:1993;249-253
32. Plantaz D., Rubie H., Michon J., Mechinaud F., Coze C., Chastagner P., et al. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients - results of the NBL 90 Study of the French Society of Pediatric Oncology. Cancer. 78:1996;311-319
33. Munro F.D., Carachi R., Fyfe A.H. Congenital neuroblastoma presenting with paraplegia. Arch Dis Child. 66:1991;1246-1247
34. Katzenstein H.M., Kent P.M., London W.B., Cohn S.L. Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol. 19:2001;047-55
35. Hoover M., Bowman L.C., Crawford S.E., Stack C., Donaldson J.S., Grayhack J.J., et al. Long-term outcome of patients with intraspinal neuroblastoma. Med Pediatr Oncol. 32:1999;353-359